SC 13G/A

Zentalis Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 98943L107

Event date: 2024-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares

7,090,108

Percent of class

9.9700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.